University of Patras
Ανάπτυξη και επικύρωση αναλυτικής μεθοδολογίας με χρήση UPLC-MS για τη φαρμακολογική αξιολόγηση AT1 ανταγωνιστών που εμπλέκονται στη θεραπεία της υπέρτασης
Abstract
dc:descriptionHypertension is one of the most common diseases that appeared in human population and the long-term hypertensive patients are at high risk for cardiovascular diseases and damage other vital organs. The Renin-Angiotensin System (RAS) plays an important role in the regulation of systolic and diastolic blood pressure. Angiotensin II is an octapeptide, which is a product of the final stage of RAS, has many biological properties and the most important of those is the increase of the blood pressure. The AT1 antagonists are the newest antihypertensine drugs and they are known as sartans. In this PhD thesis, was held the development and optimization of analytical methodology using Ultra Performance Liquid Chromatography coupled with Mass Spectrometry (UPLC-MS), for the detection and quantification of BV6 in rat plasma. Systemic administration of the synthesized analog BV6 was carried out through four different routes of administration: oral, intravenous, subcutaneous and transdermal as an alternative approach in the treatment of hypertension.The developed methodology was used for the quantitative analysis of biological samples after the systemic administration of BV6 in rats. The ultimate goal was to investigate the pharmacological profile of the test substance and the transdermal administration, as new approach in the treatment of hypertension.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Katsougraki, Pigi
- Κατσουγκράκη, Πηγή
Subjects
dc:subject × 15Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/37731